A modified liquid chromatography/tandem mass spectrometry method for predominant disaccharide units of urinary glycosaminoglycans in patients with mucopolysaccharidoses

Orphanet Journal of Rare Diseases

Volumn 9, Issue 1, 2014, Pages

  Chuang, Chih Kuang ^a,b,c   Lin, Hsiang Yu ^a,d,e,f   Wang, Tuen Jen ^a   Tsai, Chia Chen ^a   Liu, Hsuan Liang ^b   Lin, Shuan Pei ^a,d,e,g  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIPEI UNIVERSITY OF TECHNOLOGY   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^e MACKAY MEDICAL COLLEGE   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

^g NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

Author keywords

Enzyme replacement therapy; Glycosaminoglycans; Liquid chromatography tandem mass spectrometry; Methanolysis; Mucopolysaccharidosis

Indexed keywords

CHONDROITIN SULFATE; DERMATAN SULFATE; DEUTERIUM; DISACCHARIDE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE;

ARTICLE; CONTROLLED STUDY; ENZYME REPLACEMENT; FOLLOW UP; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; METHANOLYSIS; MUCOPOLYSACCHARIDOSIS; TANDEM MASS SPECTROMETRY; URINALYSIS; ADOLESCENT; ADULT; CASE CONTROL STUDY; CHILD; MUCOPOLYSACCHARIDOSES; PRESCHOOL CHILD; PROCEDURES; STANDARD; URINE; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, LIQUID; DISACCHARIDES; ENZYME REPLACEMENT THERAPY; GLYCOSAMINOGLYCANS; HUMANS; MUCOPOLYSACCHARIDOSES; REFERENCE STANDARDS; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84907429549     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/s13023-014-0135-3     Document Type: Article

References (33)

1. The mucopolysaccharidoses. EF Neufeld, J Muenzer, The Metabolic and Molecular Bases of Inherited Disease McGraw-Hill Book Company, New York, Scriver CR, Beaudet AL, Valle D, 8 2001 3421 3452
2. Clinical diagnosis of lysosomal storage diseases. LA Clarke, Organelle Diseases. Clinical Features, Diagnosis, Pathogenesis and Management Chapman and Hall Medical, London, Applegarth DA, Dimmick JE, Hall JG, 1997 45 97
3. Lysosomal disorders. GTN Besley, JE Wraith, Curr Paediatri 1997 7 128 134 10.1016/S0957-5839(97)80195-9
4. Mucopolysaccharidoses. JE Wraith, Curr Paediatri 1996 6 74 79 10.1016/S0957-5839(96)80065-0
5. Assessment of hearing loss by pure-tone audiometry in patients with mucopolysaccharidoses. HY Lin, SC Shih, CK Chuang, K Lee, M Chen, HC Lin, PC Chiu, DM Niu, SP Lin, Mol Genet Metab 2014 111 533 538 10.1016/j.ymgme.2014.02.003 24594444
6. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses-changes with age and treatment. SP Lin, SC Shih, CK Chuang, KS Lee, MR Chen, DM Niu, PC Chiu, SJ Lin, HY Lin, Pediatr Pulmonol 2014 49 277 284 10.1002/ppul.22774 23401495
7. Cardiovascular abnormalities in Taiwanese patients with mucopolysaccharidosis. SM Lin, HY Lin, CK Chuang, SP Lin, MR Chen, Mol Genet Metab 2014 111 493 498 10.1016/j.ymgme.2014.02.009 24598247
8. Assessment of bone mineral density by dual energy x-ray absorptiometry in patients with mucopolysaccharidoses. HY Lin, SC Shih, CK Chuang, MR Chen, DM Niu, SP Lin, Orphanet J Rare Dis 2013 8 71 10.1186/1750-1172-8-71 23663302
9. Natural history and clinical assessment of Taiwanese patients with mucopolysaccharidosis IVA. HY Lin, CK Chuang, MR Chen, PC Chiu, YY Ke, DM Niu, FJ Tsai, WL Hwu, JL Lin, SP Lin, Orphanet J Rare Dis 2014 9 21 10.1186/1750-1172-9-21 24513086
10. Diagnostic screening for mucopolysaccharidoses by the dimethylmethylene blue method and two dimensional electrophoresis. CK Chuang, SP Lin, SF Chung, Chin Med J (Taipei) 2001 64 15 22
11. High-resolution electrophoresis of urinary glycosaminoglycans: an improved screening test for the mucopolysaccharidoses. JJ Hopwood, JR Harrison, Anal Biochem 1982 119 120 127 10.1016/0003-2697(82)90674-1 6803608
12. Screening for mucopolysaccharidoses by analysis of urinary glycosaminoglycans. PP Dembure, RA Roesel, Techniques in Diagnostic Human Biochemical Genetics-A Laboratory Manual, Hommes FA, 1991 77 86
13. Champe PC, Harvey RA: Glycosaminoglycans in Biochemistry: Lippincott's Illustrated Reviews, 2 nd edition. Philadelphia: J.B. Lippincott Company; 1994.
14. Identification of acid mucopolysaccharides by gas chromatographic analysis of component sugars after chemical depolymerization. JF O'brien, T Gerritsen, AC Helmuth, Anal Biochem 1973 56 465 479 10.1016/0003-2697(73)90214-5 4271847
15. Differential gas-liquid chromatography method for determination of uronic acids in carbohydrate mixtures. J Lehrfeld, Anal Biochem 1981 115 410 418 10.1016/0003-2697(81)90026-9 7304968
16. Simultaneous determination of uronic acids, hexosamines, and galactose of glycosaminoglycans by gas-liquid chromatography. GC Dierckxsens, LD Meyer, GJ Tonino, Anal Biochem 1983 130 120 127 10.1016/0003-2697(83)90658-9 6869793
17. A rapid and sensitive method for the analysis of carbohydrate components in glycoproteins using gas-liquid chromatography. MF Chaplin, Anal Biochem 1982 123 336 341 10.1016/0003-2697(82)90455-9 6181710
18. A gas chromatography method for the quantitative determination of hexuronic acids in alginic acid. L Vadas, HS Prihar, BK Pugashetti, DS Feingold, Anal Biochem 1981 114 294 298 10.1016/0003-2697(81)90484-X 7304919
19. Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI. C Auray-Blais, P Bherer, R Gagnon, SP Young, HH Zhang, Y An, JT Clarke, DS Millington, Mol Genet Metab 2011 102 49 56 10.1016/j.ymgme.2010.09.003 20934363
20. Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquid chromatography-tandem mass spectrometry. H Zhang, SP Young, C Auray-Blais, PJ Orchard, J Tolar, DS Millington, Clin Chem 2011 57 1005 1012 10.1373/clinchem.2010.161141 21576268
21. An assessment of methanolysis and other factors used in the analysis of carbohydrate-containing materials. RE Chambers, JR Clamp, Biochem J 1971 125 4 1009 1018 5144210
22. Enzyme replacement therapy for mucopolysaccharidosis I: A randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-L-iduronidase (laronidase). JE Wraith, LA Clarke, M Beck, EH Kolodny, GM Pastores, J Muenzer, DM Rapoport, KI Berger, SJ Swiedler, ED Kakkis, T Braakman, E Chadbourne, K Walton-Bowen, GF Cox, J Pediatr 2004 144 581 588 10.1016/j.jpeds.2004.01.046 15126990
23. The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I. JE Wraith, Expert Opin Pharmacother 2005 6 489 506 10.1517/14656566.6.3.489 15794739
24. Mucopolysaccharidosis I under enzyme replacement therapy with laronidase-A mortality case with autopsy report. HY Lin, SP Lin, CK Chuang, MR Chen, BF Chen, JE Wraith, J Inherit Metab Dis 2005 28 1146 1148 10.1007/s10545-005-0211-x 16435211
25. Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: Results of a multinational study of recombinant human α-L-iduronidase (laronidase). JE Wraith, M Beck, R Lane, A van der Ploeg, E Shapiro, Y Xue, ED Kakkis, N Guffon, Pediatrics 2007 120 37 46 10.1542/peds.2006-2156
26. Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I. LA Clarke, JE Wraith, M Beck, EH Kolodny, GM Pastores, J Muenzer, DM Rapoport, KI Berger, M Sidman, ED Kakkis, GF Cox, Pediatrics 2009 123 229 240 10.1542/peds.2007-3847 19117887
27. Impact of enzyme replacement therapy on linear growth in Korean patients with Mucopolysaccharidosis Type II (Hunter Syndrome). SY Cho, R Huh, MS Chang, J Lee, Y Kwun, SH Maeng, SJ Kim, YB Sohn, SW Park, EK Kwon, SJ Han, J Jung, DK Jin, J Korean Med Sci 2014 29 254 260 10.3346/jkms.2014.29.2.254 24550654
28. Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II. T Higuchi, H Shimizu, T Fukuda, S Kawagoe, J Matsumoto, Y Shimada, H Kobayashi, H Ida, T Ohashi, H Morimoto, T Hirato, K Nishino, Y Eto, Mol Genet Metab 2012 107 1-2 122 128 10.1016/j.ymgme.2012.05.005 22704483
29. Plasma and urinary levels of dermatan sulfate and heparin sulfate derived disaccharides after long-term enzyme replacement therapy (ERT) in MPS I: correlation with the timing of ERT and with total urinary excretion of glycosaminoglycans. MH de Ru, L van der Tol, N van Vlies, BW Bigger, CE Hollak, L Ijlst, W Kulik, H van Lenthe, MA Saif, T Wagemans, WM van der Wal, RJ Wanders, FA Wijburg, J Inherit Metab Dis 2013 36 247 255 10.1007/s10545-012-9538-2 22991166
30. Mucopolysaccharidosis: Cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI. MM Brands, IM Frohn-Mulder, ML Hagemans, WC Hop, E Oussoren, WA Helbing, AT van der Ploeg, J Inherit Metab Dis 2013 36 227 234 10.1007/s10545-011-9444-z 22278137
31. Enzyme replacement therapy for mucopolysaccharidosis VI-experience in Taiwan. HY Lin, MR Chen, CK Chuang, CP Chen, DS Lin, YH Chien, YY Ke, FJ Tsai, HP Pan, SJ Lin, WL Hwu, DM Niu, NC Lee, SP Lin, J Inherit Metab Dis 2010 33 Suppl 3 421 S427 10.1007/s10545-010-9212-5 20924685
32. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. C Peters, M Balthazor, EG Shapiro, RJ King, C Kollman, JD Hegland, J Henslee-Downey, ME Trigg, MJ Cowan, J Sanders, N Bunin, H Weinstein, C Lenarsky, P Falk, R Harris, T Bowen, TE Williams, GH Grayson, P Warkentin, L Sender, VA Cool, M Crittenden, S Packman, P Kaplan, LA Lockman, J Anderson, W Krivit, K Dusenbery, J Wagner, Blood 1996 87 4894 4902 8639864
33. International consensus panel on management and treatment of Mucopolysaccharidosis I: Mucopolysaccharidosis I: management and treatment guidelines. J Muenzer, JE Wraith, LA Clarke, Pediatrics 2009 123 19 29 10.1542/peds.2008-0416 19117856